Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
about
Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytesHuman immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestorPeptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virusNeutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from IndiaComparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines.A host gene regulates the structure of the transmembrane envelope protein of murine leukemia virusesBifunctional recombinant fusion proteins for rapid detection of antibodies to both HIV-1 and HIV-2 in whole bloodRapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in MacaquesDeterminants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo.Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityImmunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodiesMutation-directed chemical cross-linking of human immunodeficiency virus type 1 gp41 oligomers.Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies.Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.Designing a soluble near full-length HIV-1 gp41 trimer.Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationChimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses.Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based arrayPhage display identifies two Caprine Arthritis Encephalitis Virus env epitopes.Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children.Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.Mutations within a putative cysteine loop of the transmembrane protein of an attenuated immunodeficiency-inducing feline leukemia virus variant inhibit envelope protein processing.Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequenceEpitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein.Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infectionComparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization.Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 bindingIdentification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variationLongitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoireThe membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine designCross-reactivity of anti-human immunodeficiency virus type 1 gp41 antibodies with human astrocytes and astrocytoma cell lines.Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritisB epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins.
P2860
Q24648466-3F63B13A-4994-4E11-961B-BBB82164AC26Q24675546-703C09CF-4739-44CC-BD52-B34192ED51CCQ24796207-430B3577-AD0D-46ED-BCAB-996754802B63Q27485919-534E84EC-FDC0-444D-8291-AA2D321B6F5FQ28483205-13047DCD-E964-4467-8B1C-24544910AC93Q30360326-B48BFB65-C04D-4F67-BECB-B46EBCC173EDQ30442723-FD1157D3-4DF6-474E-BC14-15EE8DFF06AAQ30825974-81FD73BB-A12D-41E8-AEA9-7094CF828A17Q33686306-69472708-D1FE-4851-BE23-2ADEC0C2ED4BQ33815502-BE5101CB-E0BB-44EE-AE1D-2131B146E921Q33819493-13C81A4F-52EE-4149-B248-12FB2C0C0C95Q33821658-4B6D0AB4-229E-4967-9BEC-8E6502174AA4Q33826951-8B791D90-26C3-4197-A756-D35D38F6BCFFQ33835295-D7726741-3167-4E41-9359-13D83EC24398Q33869882-2E18B6FF-C938-4D97-9AE4-62BF1AADEE72Q34070049-8F4AD98E-7CEA-461B-A6D7-5C4EA106F753Q34251847-EBF8E460-B2DB-4A89-A045-427095E9B0EEQ34374835-2EB37605-AA35-4D55-A953-2E2B42D5C362Q34489464-CE016E7B-64E6-480C-9FFC-0621B0E9443BQ34694812-E3CD1F78-B3A2-470B-9342-92C37F003890Q34988326-343466B6-E94E-4B9B-B1C7-587293BC0363Q35057791-23B94822-C25B-4A85-B7E8-999AABD562CAQ35183149-5AC07725-F5F2-4F1E-8B25-B95990CBCFD2Q35604169-501CBC7A-12AF-426F-B2B7-A165519458F4Q35832875-1724D662-AEB6-4A5F-A348-200D29976D75Q35837262-C7C5285C-DF4F-4C3A-8B6E-860762CFA4AEQ35837311-17395856-6CC4-4157-BBC3-7939ED527B6BQ35854300-1CBA184A-5BEB-4A07-AC05-F3C3BAB280ADQ35878159-6665B3F5-9713-46A2-BC1D-2C3215DC07FFQ35880289-BD65ACCB-843C-4CA9-8A05-10C467E1DA52Q35894855-8E04438B-3FED-4F2A-B14D-771DAC51E94FQ36012177-B7E41560-8511-4036-84A2-3209971DD698Q36174694-1A71D0B6-218E-480E-934D-C6B1A3B9F4C5Q36230268-B3E06ADA-79F9-4918-9C75-28EB81DFD688Q36231126-106EE531-CC7F-40B5-9E8C-79152BCAE6B4Q36362985-5A593EE5-7741-4B60-A679-D77E7B61BB29Q36497712-8F73F4E2-9CE8-4B96-B9E2-0A79B7C8D759Q36635851-68886AFB-F091-4815-B28A-430401EBFB04Q36636968-44516DE6-415B-42B7-A9AC-0C8107FEA0D1Q36640639-FDC3F8B3-0B84-4FFF-9B23-DF6351982A91
P2860
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Fine mapping of an immunodomin ...... human immunodeficiency virus.
@en
type
label
Fine mapping of an immunodomin ...... human immunodeficiency virus.
@en
prefLabel
Fine mapping of an immunodomin ...... human immunodeficiency virus.
@en
P2093
P2860
P1433
P1476
Fine mapping of an immunodomin ...... f human immunodeficiency virus
@en
P2093
J A Nelson
M B Oldstone
P2860
P304
P407
P577
1987-08-01T00:00:00Z